decaro

$DNLI with Fib retracements, 50/200 SMAs, and Rel Vol Index

Short
NASDAQ:DNLI   Denali Therapeutics Inc.
Short with targets of $19.6 and $16.3 and $12.2. Declines of 17.6%, 31.5%, and 48.7%.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.